AWM
RPRX icon

Apollon Wealth Management’s Royalty Pharma RPRX Stock Holding History

Apollon Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Buy
+5,504
New +$286K ﹤0.01% 1254

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Apollon Wealth Management's RPRX Position: Q2 2026 in Review

Apollon Wealth Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 5,504 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #1254 among its holdings.

107 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Apollon Wealth Management held 5,504 shares of Royalty Pharma worth $309K as of Q2 2026.
  • Royalty Pharma was a new Apollon Wealth Management position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1254 holding.
  • 107 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.